D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
CALL
Omnicom Group
OMC
$22.6B
| $1.04M | ﹤0.01% |
+14,300
| New | +$1.08M |
2026 Q2
0 quarters
|
|
3602
CALL
Carlyle Group
CG
$13.8B
| $1.04M | ﹤0.01% |
24,700
| – | – |
2025 Q2
4 quarters
|
|
3603
Phathom Pharmaceuticals
PHAT
$424M
| $1.04M | ﹤0.01% |
95,660
-36,797
| -28% | -$420K |
2025 Q4
2 quarters
|
|
3604
PUT
Copart
CPRT
$26.8B
| $1.04M | ﹤0.01% |
+36,800
| New | +$1.19M |
2026 Q2
0 quarters
|
|
3605
Wintergreen Acquisition Corp
WTG
$78.5M
| $1.04M | ﹤0.01% |
100,000
| – | – |
2025 Q3
3 quarters
|
|
3606
Cantor Equity Partners VI
CEPS
$149M
| $1.04M | ﹤0.01% |
100,000
| – | – |
2026 Q1
1 quarter
|
|
3607
PUT
Grab
GRAB
$11.5B
| $1.04M | ﹤0.01% |
275,000
| – | – |
2025 Q3
3 quarters
|
|
3608
Ardent Health
ARDT
$1.74B
| $1.03M | ﹤0.01% |
105,004
+21,290
| +25% | +$202K |
2025 Q4
2 quarters
|
|
3609
PUT
Casey's General Stores
CASY
$26B
| $1.03M | ﹤0.01% |
+1,300
| New | +$1.05M |
2026 Q2
0 quarters
|
|
3610
Richardson Electronics
RELL
$262M
| $1.03M | ﹤0.01% |
+54,336
| New | +$850K |
2026 Q2
0 quarters
|
|
3611
Cantor Equity Partners V
CEPV
$324M
| $1.03M | ﹤0.01% |
100,000
| – | – |
2025 Q4
2 quarters
|
|
3612
Walker & Dunlop
WD
$1.16B
| $1.03M | ﹤0.01% |
18,831
+76
| +0.4% | +$3.85K |
2025 Q3
3 quarters
|
|
3613
CALL
XPO
XPO
$21.3B
| $1.03M | ﹤0.01% |
5,000
| – | – |
2026 Q1
1 quarter
|
|
3614
RBB Bancorp
RBB
$449M
| $1.03M | ﹤0.01% |
37,440
+18,534
| +98% | +$444K |
2025 Q1
5 quarters
|
|
3615
iShares Russell Top 200 Value ETF
IWX
$3.39B
| $1.03M | ﹤0.01% |
+9,757
| New | +$988K |
2026 Q2
0 quarters
|
|
3616
CALL
Arteris
AIP
$945M
| $1.03M | ﹤0.01% |
+21,100
| New | +$675K |
2026 Q2
0 quarters
|
|
3617
Aemetis
AMTX
$90.2M
| $1.02M | ﹤0.01% |
623,028
+77,599
| +14% | +$190K |
2025 Q3
3 quarters
|
|
3618
Boston Properties
BXP
$9.9B
| $1.02M | ﹤0.01% |
15,400
| – | – |
2022 Q2
16 quarters
|
|
3619
GameStop Corp Warrants
GME.WS
| $1.02M | ﹤0.01% |
365,903
| – | – |
2025 Q4
2 quarters
|
|
3620
Quest Diagnostics
DGX
$26.7B
| $1.02M | ﹤0.01% |
4,814
-142,913
| -97% | -$28M |
2025 Q4
2 quarters
|
|
3621
Arbor Realty Trust
ABR
$520M
| $1.02M | ﹤0.01% |
188,131
-92,996
| -33% | -$604K |
2026 Q1
1 quarter
|
|
3622
PUT
Northrop Grumman
NOC
$77.7B
| $1.02M | ﹤0.01% |
+2,000
| New | +$1.15M |
2026 Q2
0 quarters
|
|
3623
CALL
UL Solutions
ULS
$14.7B
| $1.02M | ﹤0.01% |
+10,000
| New | +$946K |
2026 Q2
0 quarters
|
|
3624
Kelly Services Class A
KELYA
$587M
| $1.02M | ﹤0.01% |
82,947
-38,650
| -32% | -$402K |
2018 Q4
30 quarters
|
|
3625
CALL
Skyworks Solutions
SWKS
$19.6B
| $1.02M | ﹤0.01% |
15,000
| – | – |
2025 Q2
4 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.